Original source: CBC, linked here
CBC Group (“CBC”), Asia’s largest healthcare-dedicated investment firm headquartered in Singapore, today announced the appointment of Billy Cho as Senior Managing Director, Private Equity and Co-Head, Joint Value Creation.
Billy most recently served as Chief Financial Officer at Zai Lab, a global biopharmaceutical company. He joins CBC with over 20 years of healthcare experience in executive management, strategy, financing, accounting, and investment banking, across the U.S. and Asia.
Commenting on the appointment, Fu Wei, Chief Executive Officer of CBC Group, said, “We are pleased to have Billy join our growing international team. His wide-ranging experience in the healthcare industry will complement our capabilities in investment execution and portfolio management. We believe our multi-product strategy positions us well to capture opportunities to grow our business and enhance portfolio performance. We look forward to Billy’s valuable contributions to our firm’s mission.”
“I am excited to join CBC, a leading healthcare platform across multiple strategies with increasing global reach,” said Billy. “CBC is led by a deep bench of committed healthcare professionals who are uniquely experienced in both investment selection and subsequent value creation. This is an exciting time to join CBC and I look forward to helping the team pursue new investment opportunities and constantly look for ways to improve our portfolio companies.”
Based in Hong Kong, Billy also joins CBC’s Management Committee to provide guidance on the firm’s private equity investments, as well as portfolio management activities as part of the Joint Value Creation (“JVC”) team. CBC’s JVC team is an integral part of the firm’s investment strategy and a key differentiator for CBC as an investor-operator. The team works closely with our portfolio companies to create sustainable value through incubation, operational improvement, and company transformation.
Billy Cho hails from Zai Lab, where he spent over five years as Chief Financial Officer. Prior to Zai Lab, Billy was Managing Director and Head of Asia Healthcare Investment Banking at Citigroup based in Hong Kong. He helped build Citigroup’s Asia healthcare franchise as the first dedicated healthcare banker for the region in 2011. Before moving to Hong Kong in 2011, Billy was based primarily in New York working as a healthcare M&A banker for KeyBanc and Piper Sandler. He started his career with E&Y in the U.S. healthcare audit and M&A transaction advisory teams.
